ABSTRACT
The expression of three different members of the gap junction multigene family, ax (Cx43), ft (Cx32), and p2 (Cx26), was analysed in the rat implantation chamber (a structural unit containing fetal, extraembryonic and maternal components within the pregnant uterus) during mid-and late stages of gestation as well as in the delivering, post-partum and non-pregnant uterus. A differential, spatiotemporal and cell-type-specific regulation of gap junctional coexpression was observed for Pi and p2 • ″ a ″ epithelia examined (visceral, luminal and glandular), as well as for a, and ft in decidual cells and keratinocytes of the fetal epidermis, aj antigen was detected in the mesometrial stroma, mesometrial myometrium, connective tissue, mesothelia of the amnion and visceral yolk sac and in the allantoic mesodermal layer throughout gestation. In addition, expression of at in the placental basal zone and trophoblast giant cells coincided with the differentiation of these cells, fi expression was observed prominently in the chorionic villi of the placental labyrinth. The presence of Pi and P2 in the visceral epithelium (visceral yolk sac=the primary route for embryonic nourishment prior to the formation of the chorioallantoic placenta) and p2 in the chorionic villi (placental barrier=the major fetomaternai exchange route) suggests that gap junctions have an important role in fetomaternai communication.
Introduction
Gap junctions (GJ) are specialized regions of the plasma membrane containing communication channels that allow ions and small molecules to pass between cells without entering the extracellular space. A single intercellular channel comprises multiple polypeptide subunits, probably six, that span the membrane of each cell (for review, see Loewenstein, 1981, 1987). Evidence for a multigene family of related GJ proteins (connexins) that form intercellular channels between mammalian cells has been deduced by molecular characterizations of GJ cDNA clones. Thus far, four clones have been described that code for proteins of different. predicted, sizes in mammals; (a) au a 43 × 10 3 Mr Protein identified in rat heart (Beyer et at. 1987); (b) 03 a 46 × 10 3 Mr 3 protein in rat lens (Beyer et al. 1988); (c) (3U a 32 ×10 3 Mr Protein identified in rat and human liver (Paul, 1986; Kumar and Gilula, 1986); and (d) fc, a 26 × 10 3 Mr Protein found in rat liver (Zhang and Nicholson, 1989). Based on the amino acid sequences deduced from the cDNA clones together with topological analysis, it has been possible to deduce a generalized topological structure for junctional membrane proteins that contain four transmembrane domains (Zimmer et al. 1987; Beyer et al. 1987; Milks et al. 1988; Goodenough et al. 1988; Hertzberg et al. 1988; Zhang and Nicholson 1989; Yancey et al. 1989). However, although molecular characterizations have resulted in the identification of a GJ multigene family with diverse proteins, it is not yet known if and how this sequence diversity is related to functional differences between the different GJ gene products.
In the pregnant rat, two functional placentae exist concurrently throughout the later half of gestation serving as organs for the fetomaternai exchange route: a discoidal chorioallantoic placenta, and a villiary highly vascularized yolk sac placenta (Everett, 1935; Bridgman, 1948; Lambson, 1966; Merker and Villegas, 1970). However, prior to the formation of the chorioallantoic placenta, the visceral yolk sac (VYS) is the primary route for embryonic nourishment during the critical stages of organogenesis. The placental barrier (the structural and functional unit of the labyrinth separating maternal blood sinuses from fetal blood capillaries) has been described previously as a threelayered trophoblast (Jolie, 1964; Enders, 1965; Davies and Glasser, 1968), with subsequent identification of GJs in layers II and III (Forssmann etal. 1975; Metz and Forssmann, 1976).
In a previous study (Risek et al. 1990), a dynamic and tissue-specific modulation of a −y containing GJs was found in the ovaries and uterine myometrium during rat pregnancy, while /^ and /3t GJs were identified in the uterine luminal epithelium. However, information was not available on the anatomical distribution and potential contributions of the different GJ proteins to the fetomatenal exchange routes during mammalian development. These questions are of enormous importance, since the fetus and extraembryonic membranes must be considered integral parts of the female reproductive tract during pregnancy. For these reasons, the term ‘implantation chamber’ will be used to designate the structural relationship between the developing fetal (fetus and the extraembryonic membranes) and maternal components within the pregnant uterus. The present study was undertaken to determine the basic framework for the expression and modulation of three different GJ gene products in various compartments of the implantation chamber during mid-and late stages of rat pregnancy.
Materials and methods
Animals and tissue collection
Timed pregnant Wistar rats (220-250g body weight), with a gestational period of 22 days, were obtained from Simonsen (Gilroy, CA). The presence of a uterine plug was defined as day 0 (dO) of pregnancy. The animals were maintained individually on a 12 h light/dark cycle and killed by decapitation at the following stages of pregnancy: dl3, dl5, dl7, dl9, d21, d22 (parturition day) and d23. Three pregnant rats were used at each gestational stage. Implantation chambers containing intact rat concepti were removed from fat and blood vessels, embedded in OCT compound (Tissue-tek, Miles Lab., Inc., Naperville, IL), and slowly frozen in an isopentane/dry-ice bath. Implantation chambers were frozen in vertical and horizontal orientations relative to the uterine wall for subsequent transverse and longitudinal sectioning. OCT embedded samples were stored at —70 °C until use. For transcript and protein analysis, pregnant uteri were cut at the edge of placental attachment, and carefully separated from placentae and rat conceptus. The uterine region that was attached to the placenta (mesometrial stroma, also known as ‘metrial gland’) was dissected and frozen in liquid nitrogen. The placentae were separated from residual extraembryonic membranes (amnion, visceral yolk sac and allantois) and umbilical cord, and subsequently transferred to liquid nitrogen. The remaining extraembryonic membranes were removed from the fetus and frozen in liquid nitrogen. Subsequently, skin was removed from the entire fetal body (dorsal and ventral) and transferred to liquid nitrogen. All samples were stored at —70 °C until use.
Immunoblot analysis and immunohistochemistry
The preparation and characterization of the affinity-purified peptide antibodies that were used in this study (ce\S, /?iS and /y) has been described previously (Risek et al. 1990). For immunoblot analysis, liquid nitrogen frozen tissues were alkali extracted (Hertzberg, 1984) and used for analysis following protein determination (Lowry et al. 1951). SDS-PAGE and immunoblots were performed essentially as described (Risek et al. 1990). In addition, immunoblots were treated with ftJ or a^S peptide antibodies in the presence of corresponding peptides (100f/g mp1 incubation volume) to determine the antibody specificities. Indirect immunohistochemistry was performed on longitudinal and transverse sections of fresh-frozen implantation chambers containing an intact rat conceptus from different stages of pregnancy. Samples were sectioned (3-5 ^m in thickness) on a cryostat (Minotime, Int. Equipment Co., Boston, MA), collected on gelatinized slides, and processed for indirect immunofluorescence as described (Risek et al. 1990).
Immunolabeling was analysed using a Zeiss Axiophot microscope with epifluorescence. All photographs were taken with Kodak T-MAX 400 black-and-white film. The evaluation of spatial and temporal differences in density and intensity of immunolabeled antigens was based on interpretations of the investigators, since the immunohistochemistry was not subjected to a quantitative analysis. However, the relative differences were sufficiently striking to be denned as high, medium, low or undetectable.
RNA preparation, normalization of poly (A) + RNA and northern blot analysis
Total RNA was isolated by pulverization and homogenization of liquid-nitrogen-frozen tissues in guanidine isothiocyanate (Fisher) with subsequent sedimentation through a CsCl gradient by ultracentrifugation (Chirgwin et al. 1979). RNA was quantified by absorbance at 260 nm and normalized for poly(A)+ RNA content as described (Risek et al. 1990) using the procedure of Harley (1987). Northern blot analysis was performed on total RNA aliquots containing equal amounts of poly(A)+ RNA. Samples were separated by electrophoresis on 1 % agarose gels containing 0.6 M formaldehyde, transferred to nylon membranes (MSI), and hybridized with three different GJ cDNA probes: (a) rat ax GJ cDNA: a clone isolated from a rat granulosa,cell cDNA library (Risek et al. 1990) that codes for a 43 × 10 3 Mr Protein; (b) rat 0, GJ cDNA: a liver cDNA clone coding for a 32 × 10 3 Mr Protein (Kumar and Gilula, 1986); and (c) mouse & GJ cDNA: a clone isolated from a mouse liver cDNA library (Nishi et al., 1991) that codes for a 26 ×10 10 3 Mr protein. Hybridization conditions and quantitation of autoradiograms were essentially as described (Risek et al. 1990).
Results
Structural organization of the rat implantation chamber during late stages of pregnancy
The structural components of the rat implantation chamber at d21 gestational stage are illustrated in Fig. 1. The major structural features of the implantation chamber have been determined for the dl3 stage of gestation (the beginning of this GJ analysis), and they did not change substantially until delivery, except at the dl6 stage (see below). The developing fetus was separated antimesometrially from the uterine components (luminal epithelium (LE), endometrial stroma (ES) and myometrium (M)) and the extraembryonic membranes (EEM; amnion, visceral and parietal yolk sac). The parietal yolk sac (PYS) was in contact with the trophoblastic central zone and the decidua capsularis (DC). This region was characterized by the presence of trophoblastic giant cells (GC) and maternal blood sinuses. However, by dl6, the parietal yolk sac (PYS) and the decidua capsularis degenerated and retracted to the peripheral margins of the chorioallantoic placenta exposing the uterine LE to the absorptive cells of the visceral epithelium (VE). Following this exposure, the structural features of the implantation chamber were reorganized as shown in Fig. 1 for the d21 stage. The definitive chorioallantoic placenta, which was vascularized by both fetal and maternal blood vessels at dl2 (except the lateral margins of the BZ) was the major route for fetomaternal exchange (known as labyrinthine placental barrier). The placental basal zone (BZ), which was composed predominantly of cytotrophoblastic elements, formed the area between the labyrinth and the decidua basalis (DB), and it was characterized by the presence of maternal blood sinuses and trophoblastic GC adjacent to the DB. The decidua basalis, which was easily identified by densely packed cells, formed the outermost placental region adjacent to the uterine LE (laterally) and the mesometrial stroma (MS; centrally). The term ‘mesometrial stroma’ has been used to refer to the uterine region of the mesometrial triangle, also known as the metrial gland. As pregnancy progressed, the villus structure of the epithelial layer of the VYS became more extensive in regions proximal to the placenta (mesometrial), as opposed to a more regular surface in antimesometrial regions. In addition, the placental labyrinth increased significantly in size, whereas the BZ and DB were reduced in size. Furthermore, the epidermis (Ep) of the developing fetal skin increased in thickness (the individual layers were distinguishable at d17), while the outermost cell layer (stratum corneum) was keratinized at d19.
Immunohistochemical analysis of α1, β1, and β2 GJ antigens in the implantation chamber during mid-and late stages of pregnancy
To determine spatiotemporal modulations in expression of three different GJ gene products, an immunohistochemical analysis was performed on various regions of the rat implantation chamber from dl3 to one day post-partum (d23) at 48 h intervals. Results from these selected stages (d13, d17, d21, d22=parturition, and d23) are presented chronologically, to show the striking temporal transitions that occur. Finally, the results are compared with the pattern of expression in the non-pregnant uterus.
Stage dl3
At this stage, the most prominent staining of GJ protein was observed using /?2j peptide antibodies. fi2 antigen was expressed at comparable levels in the uterine LE in the antimesometrial (Fig. 2A) and mesometrial portions of the implantation chamber (Fig. 2C). However, /32 antigen was not detected in the glandular epithelium (GE; Fig. 2A). Although /?2 antigen was localized in the DC (Fig. 2B), it was not detected in the central zone containing TB GC and in the adjoining PYS. /32 was present also in lateral regions of DB (Fig. 2C) adjacent to the uterine LE, with comparable amounts localized in the central portion adjacent to the MS (data not shown). The thickness of the DB was maximal at this stage, and it decreased gradually with progressing pregnancy. Regional differences for fa GJ expression were observed in the VE, with less antigen detected in antimesometrial regions where the surface was more regular (data not shown) compared to a slightly higher level in more villiated structures adjacent to the placenta (VE; Fig. 2D). The most prominent staining of/.L was observed in the placental labyrinth (L) which is extensively vascularized with both fetal and maternal blood vessels. fi2 was the only GJ antigen detected in the trophoblastic epithelia of the chorionic villi (CV), the structures that form the placental barrier (Fig. 2D). Since the trophoblastic epithelium of the CV was not entirely developed at this stage of pregnancy, the stained layer was thinner than at later stages of pregnancy (see Fig. 3B, C for dl7 stage) and the villi encompassed a larger area of the labyrinth. The labyrinthine area was relatively small compared to other regions of the placenta (BZ and DB), but it increased during pregnancy reaching a maximal size just prior to term. At dl3, fa was detected in variable amounts in the epidermal layer of the developing fetal skin (Fig. 2E).
ocx GJ antigen was localized in the DC (Fig. 2F) and in the mesothelia of the amnion and the VYS (Fig. 2G). This antigen was abundant in the lateral (data not shown) and central portion of DB (Fig. 2H). Note that at this stage, aY was not expressed in the adjacent layer of GC or in the placental BZ (Fig. 2H). a, antigen was expressed at high levels in the MS and in the longitudinal layer of the lining myometrium delimiting both sides of the mesometrial triangle (Fig. 2J). In contrast, av was not detectable in antimesometrial regions of the myometrium throughout pregnancy except at parturition day (d22). ax antigen was localized also in the CT of the uterine myometrium and endometrium, with a higher abundance in the mesometrial regions (Fig. 2K). a> antigen was detected in the allantois (Fig. 2L). At this stage of pregnancy, punctate <xx staining was detectable in the Ep of the developing fetal skin (Fig. 2M).
The most prominent spatial differences in GJ expression within the implantation chamber were observed for fa in the uterine LE. fa antigen was detected in the cytoplasm (annular form) of the uterine LE in some mesometrial regions (Fig. 20), whereas in other regions the staining was also localized to the cell surface borders (macular form) of epithelial cells (Fig. 2Q). fa was not detected in the GE (Fig. 2Q). Furthermore, fa antigen was not observed in the antimesometrial regions of the uterine LE (Fig. 2R). The macular or plaque-like form of fa antigen was detected in the VE with less staining in the antimesometrial compared with mesometrial regions (Fig. 20). Thus, in addition to coexpression of aL‘and fa proteins in decidual and epidermal cells, /32 was coexpressed with fa in epithelial cells of the uterine luminal and visceral endoderm.
Stage dl7
At this stage of pregnancy, there was an increase of j52 protein in antimesometrial regions of the uterine LE and VE, compared with dl3, but fa was not detectable in the GE (Fig. 3A). The fa expression increased in the developing fetal Ep where the antigen was localized between cells of the stratum basalis, stratum intermedium, and periderm (Fig. 3A). The stratum corneum was not yet developed at this gestational stage. The abundance of fa antigen in mesometrial regions of the VE (Fig. 3B, C) was higher than in antimesometrial portions. Structurally, this region was characterized by increased villus formation in the VYS, accompanying the proliferation of underlying embryonic vessels. Prominent temporal differences in ^ expression were observed in the trilaminar trophoblastic epithelia of the CV (Fig. 3B); the stain density increased substantially in these layers from dl3 to dl7. The demarcation line between the labyrinth and the adjoining BZ was characterized by the absence of ft antigen in the latter, although single puncta were detected in some regions of the BZ proximal to the labyrinth (Fig. 3C). ft was expressed in comparable amounts in the lateral regions of DB adjacent to the uterine LE (Fig. 3D) and in the central portion adjacent to the MS (Fig. 3E). Also, differences in ft abundance were not observed in the antimesometrial and mesometrial portions of the uterine LE (compare Fig. 3A, D).
a\ protein was coexpressed with ft in the stratum basalis, stratum intermedium, and in the periderm of the developing fetal Ep (Fig. 3F). The ocy abundance increased markedly in these layers compared with dl3, as well as in the placental BZ and the adjacent layer of GC (Fig. 3H, I), ocx antigen increased also in abundance in the allantoic mesoderm (Fig. 3K).
Spatiotemporal differences were observed for ft expression in antimesometrial and mesometrial regions of the uterine LE compared to dl3. At dl7, a macular form of ft was detected in antimesometrial and mesometrial portions, with a higher level in the latter (Fig. 3L, M). In addition, temporal differences for ft expression were observed in the VE. The expression was much higher than at dl3 with a comparable abundance in antimesometrial and mesometrial regions (Fig. 3L, M). However, ft connexin was not detected in the placental labyrinth (L; Fig. 3N) or in the PYS lining Reichert’s membrane (Fig. 3P). Thus, relative to dl3, the coexpression of ft and ft increased in visceral endoderm and uterine lumenal epithelium at dl7, and the coexpression of at and ft increased in the developing fetal epidermis. In contrast, the coexpression of ax and ft proteins in decidual cells was comparable in abundance to d!3.
Stage d21
The structural organization of the implantation chamber at d21 has been presented in Fig. 1. Following dl7, the major structural features did not change markedly, except for the increased diameter of the implantation chamber due to the enlarging fetus and placenta, ft expression in the uterine LE did not change during late stages of gestation, and it was not detectable in the GE (Fig. 4A). However, the ft expression pattern differed markedly in the VE, compared to earlier stages. There was a substantial loss of ft antigen in the antimesometrial hemisphere, and it was barely detectable in regions proximal to the placenta (Fig. 4A, B). Relative to dl7, there were no changes in ft expression in the CV of the placental labyrinth at d21 (data not shown). However although the expression level of ft in a single CV was comparable with preceding stages of pregnancy, the total ft. content increased due to the increased overall growth of the labyrinth, ft content increased also in the differentiated epidermal layers of the fetal skin (stratum spinosum and stratum granulosum), but was no longer detectable in the periderm (Fig. 4B). Striking differences in ft expression were detected in lateral and central regions of the DB. The high expression level in lateral regions (Fig. 4C) was comparable to dl7, whereas a dramatic loss was observed in the central region adjacent to the MS (Fig. 4E).
An increase in ax Was detected one day before delivery in the fetal Ep. ax antigen was localized at high levels at the cell borders of spinous and granular layers, and to a lesser extent in the stratum basalis (Fig. 4F). ax was not detected in the periderm. ax antigen was expressed also in the mesothelia of the amnion and the VYS in comparable amounts to dl7 (Fig. 4F). However, spatiotemporal differences were observed in the circular myométrial smooth muscle layer one day prior to parturition. ax was detectable in the regions proximal to the mesometrium (Fig. 4G), but was not detected in the antimesometrial portion (data not shown). In contrast, ocx was not expressed in the adjacent longitudinal muscle layer at this stage (Fig. 4H) but was abundant on parturition day (compare Fig. 4G, H with Fig. 5E, F for rapid induction of myométrial GJs related to the parturition process), ax was expressed at high levels in the DB, comparable to dl7. Spatial differences were not detected, since the abundance was similar in the lateral (data not shown) and in the central portion of DB (Fig. 41), in contrast to the ft expression pattern where there was a dramatic decrease in the central region (see Fig. 4E). ax was expressed at high levels in the MS (Fig. 41) and in the lining myometrium (data not shown), comparable to late stages of pregnancy. The level of ax in the placental BZ did not change since dl7, except in the layer of GC where an increased staining was observed (Fig. 4J). An increased <xx staining was also observed in the mesodermal layer of the allantois (Fig. 4K).
As reported for dl7, ft was expressed in a spatially specific manner in the uterine LE one day prior to parturition, ft was expressed at low levels in the antimesometrial regions (Fig. 4M), and at higher levels in the mesometrial portion (Fig. 4O). However, in contrast to ft, different results were obtained for ft expression in the uterine LE of different animals at d21. In addition to uterine regions, where ft was detected at the borders of epithelial cells, ft was also found in the cytoplasm indicative of internalized (annular) GJs (Fig. 4Q). Regional differences were detected in the VE: ft was not detectable in the antimesometrial region (Fig. 4M), but it was abundant in regions proximal to the placenta (Fig. 4O). However, as observed for ft expression at this stage, the ft expression pattern varied in the VE in different animals. The abundance fluctuated between undetectable and barely detectable levels in the antimesometrial regions in some animals, but remained high in the regions proximal to the placenta. Thus, at d21 (the day before parturition) a striking cell-type-specific modulation of spatiotemporal coexpression was observed for: (a) ax and ft in the maternal decidua (high coexpression of ax and ft in lateral regions versus specific loss of ft GJs in the central portion; compare Fig. 4E and 4I); (b) ft and ft GJs in the VE proximal to the placenta (specific loss of ft, while the ft level remained constant; compare Fig. 4B and 4O); and (c) ft and ft GJs in the LE (annular form of /3l5 while β2 remained unaffected; compare Fig. 4A and 4Q).
Stage d.22 (parturition day)
Following parturition, regional differences were detected for & expression in the uterine LE. This antigen was expressed at lower levels in the antimesometrial region (Fig. 5B) than in the mesometrial region (Fig. 5D). The staining density in the mesometrial region of the LE was comparable to late stages of pregnancy suggesting that ft. was not reduced in this region following delivery. Striking results were obtained by analysis of the GE: fL Was not detectable in these epithelia throughout mid-and late stages of pregnancy (since d11 stage), but was detectable at low levels on parturition day (Fig. 5B), and increased following parturition (see Fig. 6B).
<Xi protein was expressed at high levels in the circular and longitudinal smooth muscle layers of the myometrium (Fig. 5E, F) with no detectable differences in antimesometrial and mesometrial regions, a^ was detected at high levels in the MS of the mesometrial triangle (Fig. 5G), which was comparable to late stages of pregnancy. Furthermore, ai was present in the CT of the ES, adjacent to the LE (Fig. 51).
Regional differences were observed for ft expression in the LE on parturition day. ft immunoreactive elements were detected exclusively in the cytoplasm of uterine LE cells in antimesometrial regions indicative of the internalized (annular) form of the ft antigen (data not shown). However, in the central portion of the uterus, ft antigen was localized to the cell surface borders of epithelial cells, as well as to intracellular regions (Fig. 5J). In mesometrial regions, the predominant form of ft was localized to the borders of epithelial cells (Fig. 5K). ft was not detected in the GE (data not shown). Thus, the parturition day was characterized by: (a) a high expression level of ax in the uterine myometrium (circular as well as longitudinal); (b) the appearance of ft GJs in the GE; and (c) a decrease of ft in the LE.
Post-partum stage
The level of ft expression was reduced in the LE one day after parturition to the lowest level observed during this study (Fig. 6B). Differences were not observed in antimesometrial and mesometrial regions. In contrast, the abundance of ft increased in the GE compared to d22 (Fig. 6B). A complete loss of av antigen was observed in the circular and longitudinal layers of the myometrium one day following parturition (Fig. 6C, D). In these layers, a^ was detected only in the CT region of the smooth muscle. In addition, ax as expressed in the MS (remnants of the metrial gland; Fig. 6E) at a reduced level compared with the pre-partum stages. Finally, ft was not detectable either in the LE or GE of the post-partum uterus (Fig. 6G).
Non-pregnant uterus (proestrus)
For comparative purposes, the differential expression pattern of <X\ ft and ft GJ proteins was analyzed during the proestrus cycle. The results for the complete four stages of the rat estrus cycle will be presented elsewhere. At proestrus, ft was expressed at high levels in the LE, comparable to levels observed during the late stages of pregnancy (Fig. 7B). However, in contrast to late stages of pregnancy, ft was expressed also in the GE (Fig. 7B). <X\ was localized in the CT region of the endometrium, as well as in the ES region proximal to the LE (Fig. 7D), and it was not detected in the myometrium except in CT areas (data not shown),ft was coexpressed with ftm the LE and GE (Fig.7F), with ft at lower levels than ft. Collectively, the nonpregnant uterus at proestrus was characterized by: (a) a coexpression of ft and ft. in the glandular and luminal epithelia; and (b) expression of <xx in the endometrial stroma lining the uterine epithelium.
Analysis ofaj and ft GJ proteins in different components of the dl9 implantation chamber
Different components of the implantation chamber at dl9 were analyzed by immunoblotting to confirm the results of the immunohistochemical analysis for ft and <1 localization. In addition, since equal amounts of NaOH-insoluble material were used, a semiquantitative comparison for different samples was obtained. The placental sample (Fig. 8, ft, lane A) contained the highest level of ft protein. In addition to the ft monomer-(26 ×10 10 3 Mr), aggregates of dimeric (38 ×10 10 3 Mr) trimeric (47×103yV/r) and tetrameric (60×10 10 3 Mr) forms were detected. Consistent with the immunolocalization data, monomeric, dimeric and trimeric forms of the ft. GJ protein were detected also in the EEM sample consisting of VYS, amnion and allantois (Fig. 8, ft, lane B). In contrast to the placental sample, the 47× 103Mr band was the most prominent component indicating a high stability of the trimer following solubilization in the presence of SDS and ft mercaptoethanol. Monomeric and dimeric forms of the ft protein were detected in the sample of MS (Fig. 8, fix, lane C), and relatively large amounts were present m the fetal skin sample (Fig. 8, ft, lane D). The antibody specificity for ft protein was determined by a peptide competition assay: in the presence of the ftJ peptide (+ lanes in Fig. 8; ft), none of the blotted proteins bound ftJ peptide antibodies.
In parallel with the ft GJ protein analysis, the ocx protein (43×10 10 3 Mr) was detected in all samples examined (placenta, extraembryonic membranes, mesometrial stroma and fetal skin (Fig. 8, a’]). In addition to the <xv polypeptide (43× 10 3 Mr), a band of 40× 103 Mr was detected in the placental material. This band most likely represents either proteolytic degradation of the 43× 10 Mr protein or a non-phosphoiylated form of this product (Musil et al. 1990). Detection of ax protein in the different samples by immunoblot analysis was consistent with the immunohistochemical localization results for a^ antigen in those same samples.
No Pi protein was detected in any of these four samples by immunoblotting. Therefore, the immunolocalization of ft antigen in the LE and VE could not be confirmed either at the protein or transcript level (see below).
Analysis of a} and ft GJ transcripts in different components of the implantation chamber
The content of a-, and ft GJ mRNA was determined by northern blot analysis. The level of expression of the a\ transcript (3.3 kb in size) did not change in the placenta during late stages of gestation (dl7-d21; Fig. 9A, av). Similarly, the high level of placental ft transcripts (2.8 kb in size) remained constant during the same stages (Fig. 9A, ft). However, the a-j transcript, detected in EEM (amnion, allantois and visceral yolk sac) gradually increased in abundance from dl7 until one day before delivery (Fig. 9B, <x}) Relative todl7, the at GJ mRNA increased 1.7 times at d 19 and 3.2 times at d21. Analysis of the ft transcript in EEM revealed a similar modulation pattern (Fig. 9B, ft). The transcript abundance at d19 increased 1.5 times over d17, reaching a maximum at d21 (2.2 over d17 stage). However, the abundance was extremely low compared to the ft GJ mRNA level of placental samples, which was 30 times the amount detected in the EEM at d21. cxx transcripts in the MS were constitutively expressed during late stages of pregnancy, and they remained constant on parturition day when analyzed 3h after delivery (Fig. 9C, a-,). The abundance decreased dramatically to 0.1 times the previous stage in the one day post-partum uterus (d23). The level of the a-, transcript in the pre-partum samples, as well as in the MS isolated 3h after delivery, was comparable in abundance to the EEM at dl9, and it was equivalent to about 70% of the placental a\ level, ft GJ mRNA was just detectable in MS samples of pre-partum and parturition stages, followed by an increase in the one day post-partum sample (Fig. 9C, ft). Although ft transcripts and protein were detected in MS, the corresponding antigen could not be localized in this region. The most likely explanation for this discrepancy might be a cross contamination of the mesometrial stroma with the decidua basalis and/or the luminal epithelium (both tissues with high ft abundance) during tissue dissection. Consequently, it will be important to determine by in situ hybridization if cells of the mesometrial stroma are producing ft mRNA. The identification of a* protein in the epidermal layers of the d21 fetal skin (stratum basalis, spinosum and granulosum) by immunolocalization and immunoblotting was consistent with the detection of ax GJ mRNA in this specimen (Fig. 9D, a\). The highest level of a-j transcript was detected in the fetal Ep, where the abundance was 3 times the value of the placental samples. Similarly, the detection of ft mRNA (2.8kb) in the fetal skin (Fig. 9D, ft) was consistent with immunohistochemical and immunoblot results. The ft transcript abundance in the skin was about 30% of the placental ft transcript level, and the ft transcript was not detected in any of the samples examined (data not shown).
Summary of results and expression map of GJ gene products in the rat implantation chamber during late stages ofpregnancy
a, GJs
Myometrial (M) ax GJs were present throughout pregnancy only in the longitudinal myometrium next to the mesometrial triangle. At the same time, ax GJs were not detected in other areas of the uterine myometrium until d21, when a punctate staining was observed in the circular layer. At the parturition day, however, a peak of ax expression was observed in the circular and longitudinal myometrium throughout the uterine wall, reaching an undetectable level in the one day post-partum uterus. These observations are consistent with the modulation of the myometrial ax GJ transcripts reported previously (Risek et al. 1990). Myometrial ocx GJs were not observed in the nonpregnant uterus, ax protein was constitutively expressed in the MS (metrial gland) at high levels throughout pregnancy. The expression level remained constant following delivery, but then it was reduced in the remnants of the metrial gland in the one day postpartum uterus. The localization of ax antigen in MS was confirmed by transcript and protein analysis. ax GJs were also present in CT of the uterus with higher levels in the mesometrial portions of the implantation chamber, and they were also expressed in CT and ES of the non-pregnant uterus at proestrus. ax GJ protein was abundantly expressed in decidual cells without any detectable differences in the lateral and central regions of DB. Note that ocx antigen was not detectable in the placental BZ and TB GC at d13. The expression started at d15 and increased at dl7. The abundance remained constant in BZ at d21, but increased slightly between GC. The detection of placental ax antigen was confirmed by immunoblot and northern blot results. ax GJs were also expressed in the mesothelia of the VYS and amnion as well as in the mesodermal layer of the allantois. With progressing pregnancy, a gradual increase of <xx expression was observed in allantois only. These observations were in agreement with protein and transcript analysis. A gradual increase of ax expression was also observed during development of the fetal epidermis (Ep), where ax was coexpressed with (32 protein (see below).
15, GJs
/3x GJ antigen detected in epithelial cells (LE, VE, GE) was always coexpressed with fc protein. In effect, no cells were identified that expressed [5X connexin only. fix was not detectable in the antimesometrial regions of LE at d13, but was present in some mesometrial portions between the epithelial cell borders and in others within the cytoplasm, indicative of internalized GJs. The abundance of macular ft forms increased gradually in both antimesometrial and mesometrial regions. However, at parturition day the most prominent staining was localized within the cells of LE. ft antigen was not detectable in the one day post-partum uterus, but was abundantly expressed in the LE of the non-pregnant uterus at proestrus. Bx expression increased gradually in VE with advancing pregnancy, with higher abundance in the regions proximal to the placenta (mesometrial). Prominent spatial differences were observed at d21, when ft was only expressed in the mesometrial regions of the VE. Note the absence of ft in the GE of the pre-and post-partum uterus, and its expression at the proestrus of the non-pregnant animals.
ft GJs
ji2 was expressed in the LE with undetectable regional differences (antimesometrial, mesometrial), and increased in both regions with advancing pregnancy. The abundance remained high at parturition day, and decreased in the post-partum uterus, ft was not expressed in the GE of the pre-partum uterus; the expression began at parturition day, and increased following parturition reaching a level comparable with the non-pregnant uterus, ft expression gradually increased in the VE with higher abundance in the mesometrial regions during late stages of gestation. However, at d21 a dramatic loss was observed, reaching undetectable levels in some animals. The localization of ft antigen in the VE was supported by the detection of the corresponding transcript and protein in the EEM. In analogy to the VE, similar results were obtained for ft expression in the DB. ft was expressed in high abundance in decidual cells throughout gestation, except at d21. At this time, a dramatic loss of ft was observed in the central region of DB, while the abundance remained high in the lateral portions, ft GJ antigen was very abundant in the trophoblastic epithelia of the CV forming the placental barrier. This high expression level was consistent with the high placental ft transcript and protein levels, ft antigen increased gradually in abundance in the fetal epidermis with progressing development. Epidermal ft GJ expression was also confirmed by immunoblot and northern blot analysis. Thus, the only cells expressing fa GJ protein were the trophoblastic epithelia of the CV; in all other cell types ft was coexpressed either with <xx (decidual and epidermal cells) or with ft (epithelial cells of LE, GE, VE). However, at d21 the coexpression was differentially regulated for a^/ft in decidual cells, and for ft/ft in the VE, and ft/ft in the LE atdl3, d21 and parturition day. The a1/J32 coexpression pattern observed in the fetal epidermis differed with progressing development as a consequence of cell proliferation and differentiation of kératinocytes. A detailed analysis of these changes is currently in progress.
The expression pattern of ax, ft and ft GJ proteins, together with the structural features of the fetomaternal relationship, are schematically presented in Fig. 10. A color code has been used to illustrate the spatial expression of single GJ gene products: ax, blue; ft, red; ft, yellow. The coexpression is presented as a combination of corresponding elementary colors: ax/Bx, purple; a^/ft, green; ft/ft, orange; (note that ax/ft coexpression (purple) was not observed), ft and ft proteins (orange) were coexpressed in the epithelia of the uterine lumen and VYS, with higher ft abundance in both epithelial tissues. In contrast, neither ft or ft was expressed in the GE during mid-and late stages of gestation. ax and ft proteins (green) were abundantly coexpressed in cells of the decidua basalis (DB) and the fetal epidermis (Ep). ax protein (blue) was constitutively expressed in the metrial gland (mesometrial stroma; MS) and the lining mesometrial myometrium, and to a lesser extent in the connective tissue and extraembryonic membranes (EEM= mesothelia of the amnion and VYS, and mesodermal layer of the allantois). In addition, ax was expressed in the placental basal zone (BZ; trophospongium) and in the layer of trophoblastic giant cells, ft protein (yellow) was abundant also in the trilaminar trophoblastic epithelium of the chorionic villi, constituting the placental barrier.
Discussion
In the present study, the spatiotemporal expression of three different GJ gene products has been analyzed in various compartments of the rat implantation chamber using specific peptide antibodies and cDNA probes during mid-and late stages of pregnancy. Several relevant observations have resulted from this analysis. First, spatiotemporal, differential and cell-type-specific GJ coexpression has been observed for ft and ft gene products in the epithelia of the uterine lumen and VYS, as well as for ax and ft in the cells of the maternal decidua and fetal epidermis. Moreover, differential regulation of GJ coexpression has been observed for ax and ft proteins in the central portion of d21 DB and for ft and ft in VE. Second, evidence was provided for GJ expression as a consequence of cell differentiation: (a) differentiated decidual cells coexpressed ax and ft, whereas expression was not observed in the undifferentiated endometrial stroma; (b) the absence of ax antigen in the TB GC and in the BZ at dl3, and expression of ax at dl5 coincided with the differentiation of GC and parenchymal TB. Third, GJ expression was observed at sites of fetomaternal exchange: (a) coexpression of ft and ft in the VE of the yolk sac placenta; and (b) high expression of ft in the trilaminar TB (placental barrier) of the chorioallantoic placenta. Fourth, the maximal number of GJ gene products coexpressed at any given time was 2. Of all three GJ gene products examined, a cell-type-specific coexpression was observed only for aA/ft and for ft/ft combinations. The coexpression of ar//Jr was not observed. Fifth, a correlation was observed between a cell-type-specific GJ expression and the germ layer origin: ax Was expressed in mesodermal derivatives, whereas the endodermal derivatives coexpressed fix and f$2 GJs. The ectodermal derivatives (surface ectoderm) were characterized by the coexpression of a\ and /52. Finally, evidence was obtained that provides the basis for an additional potential fetomaternal exchange route consisting of the fetal skin (periderm/epidermis), extraembryonic membranes and the uterus.
Spatiotemporal modulation of GJ expression in the rat implantation chamber
Pi and fa GJs were detected at the sites of the fetomaternal exchange routes, in the placental barrier and in the epithelium of the visceral yolk sac. Based on the immunohistochemical analysis, /A-containing GJs were the major contributor to intercellular channels in the placental barrier. At d13, fij was expressed to a lesser extent in the trophoblastic component of the placental barrier than at later stages of gestation; it has been reported that the placental barrier is not yet completed at this stage of development (Jollie, 1964). A maximal expression of/.L was observed at d17 when all residual parenchymal TB disappears; i.e., at the time that the labyrinth development is completed. Following d17, the fi2 abundance did not change in the structures of the placental barrier until parturition. Thus, in contrast to d13 and d17 stages, where the metabolic activity of the placental barrier was indicated by both the modulated abundance of/32 expression within the trilaminar TB of a single CV (dl3) as well as by an increased number of CVs (dl7), during late stages of pregnancy the intercellular coupling was regulated primarily by an increased number of CVs due to the expanding labyrinth. The detection of fi2 antigen in the CV of the three-layered TB is also consistent with the ultrastructural identification of GJs between syncytial layers (Forssmann et al. 1975; Metz and Forssmann, 1976). Since (52 expression coincided with the development of the placental labyrinth, analysis of GJs may provide an additional approach to understand the functional role of the major fetomaternal exchange route.
Although the VYS has been studied ultrastructurally (Lambson, 1966; Padykula et al. 1966; Merker and Villegas, 1970), GJs have not been reported. The presence of fii and//2 connexins in the VE is consistent with the potential role of the VYS as a functional fetomaternal exchange route for passage of ions and small molecules. Consequently, f5± and /32 GJs could provide pathways for nonselectively absorbed material from the uterine lumen by the VE, which is subsequently transported to the fetal blood circulation. Furthermore, the loss of GJs in the peripheral fetomaternal exchange route just prior to parturition might reflect the onset of fetal independence. GJ immunoreactive elements were not detected in the three-layered PYS (TB/Reichert’s membrane/endo-derm complex) which was interposed in the yolk sac placenta exchange route from maternal to fetal blood until dl6. GJs were absent between the cells of the PE since there was a physical separation between these cells, exposing the Reichert’s membrane directly to the yolk sac cavity. As a consequence of this physical separation of the parietal cells from each other, transport to the absorptive VE is most likely by diffusion from Reichert’s membrane directly across the yolk sac cavity as suggested by Jolie (1968).
The expression of oj at the borders of TB GC and in the BZ started at dl5 and coincided with the differentiation of TB GC and trophospongium, which occurred at the same gestational stage as reported by Jollie (1965). In addition, ax expression by GC might be related to diverse secretory and endocrine functions of these cells approaching parturition (Deane et al. 1962; Sherman, 1983).
The transformation of endometrial fibroblast-like stromal cells into decidual cells is characterized by large • numbers of GJs between the decidual cell population in the pregnant mouse uterus (Finn and Lawn, 1967), in the deciduoma of the pseudopregnant rat uteri (Kleinfeld et al. 1976) and in the pregnant rat uterus (Welsh and Enders, 1985; Parr et al. 1986). The high level of a* and (32 antigens observed between decidual cells is consistent with these observations. Accordingly, the decidual GJs may contribute to synchronizing decidual cells for secretory, differentiation and degradation processes, as suggested by Ono et al. (1989). Furthermore, junctional communication between decidual cells may form functional syncytia, also known as ‘communication compartments’ (Lo and Gilula, 1979; Pitts and Kam, 1985). Consequently, the undifferentiated endometrial fibroblast-like stromal cells, which are not joined to the decidual cells via GJs, would remain outside the communication compartments. The loss of /?2 GJs in the central region of DB one day before delivery could result in the reduction of intercellular coupling activity; this might be important for facilitating the process of placental detachment from the uterus (placental attachment site) since the detachment is initiated in the central region adjacent to the MS. The unaltered <L abundance at this stage suggests that there is a differential regulation of «i and (32 expression in decidual cells. Consequently, cultured decidual cells may be useful for studying hormonal regulation of axand fi2 GJ coexpression.
In contrast to decidual cells (differentiated endometrial stromal cells), which coexpressed ai and f^ cells of the MS expressed a\ only. This difference may be notable since cells of the mesometrial stroma (metrial gland) were fibroblast-like cells, which did not differentiate into typical decidual cells but continued to proliferate (Peel, 1989). The spatiotemporally regulated <*! antigen expression between smooth muscle cells of the uterine myometrium was consistent with the modulation of myometrial ax GJ transcripts as reported previously (Risek et al. 1990). Further, the detection of ai in the mesometrial myometrium lining the mesometrial stroma (metrial gland) may reflect regional differences in the local cell environment in two different uterine compartments, i.e., undifferentiated endometrial stroma versus proliferating mesometrial stroma.
Although dynamic spatiotemporal changes in jii and ^2 coexpression were observed between proliferating cells of the luminal and glandular epithelium, there are currently no explanations for these results. However, one possibility is that the expression patterns may be related to the secretory activities of these two uterine glands.
GJs have been described in fetal and adult mammalian skin by ultrastructural (Breathnach et al. 1972; Caputo and Peluchetti, 1976) and dye-coupling analysis (Salomon et al. 1988; Kam and Pitts, 1989). In the present study, two different members of the GJ multigene family («i and ft) were identified in the fetal epidermis, where the aA/ft coexpression coincided with the kératinocyte differentiation and proliferation process.
Possible physiological and developmental implications
During the fetal development of mammals, the free surface of the epidermis is covered by periderm that is continuous with the lining of the amniotic cavity. Direct physiologic evidence demonstrating that the periderm (before epidermal keratinization) is definitely involved in maternal transport was provided by Parmley and Seeds (1970). It is reasonable to extend these observations to the less analysed rat periderm since: (a) these cells display structural properties of an absorbing epithelium (Bonneville,.1968)3. and .(b) injection of .a radioactive tracer ([3H]thymidine) into the amniotic fluid was used to demonstrate the uptake of the label by fetal rat epidermis (Stern etal. 1971). Consequently, the identification of ocx and ft proteins in the outermost epidermal layer may provide an additional parameter that can be used to understand the function of the periderm. The high levels of <xx and ft GJs throughout the fetal body surface (including periderm) may facilitate indirectly the interaction of developing skin with the prenatal environment (for example, amniotic fluid) for essential functions such as absorption and secretion of metabolic products. The presence of ocx in the mesothelia of the amnion and visceral yolk sac lining the amniotic or visceral yolk sac cavity respectively, could provide an additional, bidirectional peripheral pathway for the transport of small molecules and ions between the maternal and fetal components. On the maternal side, ft and ft GJs in the luminal and visceral epithelium could provide a cell-cell mechanism for passage through the uterine/yolk sac cavity. Thus, molecules secreted by the uterine luminal epithelium have to cross three different cavities (diffusion) and two interposed extraemhryonic membranes (absorption/secretion) to be absorbed by the periderm of the fetal epidermis (see Fig. 10). This potential peripheral communication route is consistent with the concept of an ‘Organ Communication System’ as discussed by Casey and MacDonald (1986).
The results of the present study indicate that the expression pattern of each GJ gene product was correlated with embryonic tissue origin. So far, mesodermal derivatives (connective tissue, myometrium, mesothelia, dermis) expressed ax, while the endoderm derived tissues (epithelia) expressed ft and ft. The epidermis, which is a surface ectodermal derivative, expressed ax and Pi.
Although the present study has provided several examples for spatiotemporal coexpression of GJ gene products in different cell types during rat pregnancy, the biological implications are not understood yet. However, the spatial and temporal modulation of coexpression presumably indicates that there are mechanisms for regulating intercellular coupling activity between synchronized cells within communication compartments. Further, the differential regulation of coexpression and specific degradation of only one GJ gene product observed in several cell types indicates the existence of homo-oligomeric GJ channels, an observation that is not consistent with the concept of hetero-oligomeric GJ channels (oligomers containing different gene products) as discussed by Traub etal. (1989). It is interesting to note that high levels of ft were found only in the placental barrier. Consequently, it is possible that P2 generates channels that are utilized for intercellular coupling activity in situations where little to no regulation is required. Finally, although results indicate a temporal switch in GJ coexpression (low ax level in epidermis relative to ft at dl3; undetectable or internalized ft in luminal epithelium during mid stages), as well as the termination of expression of certain GJ gene products in different cell types (ft in visceral epithelium and in the central region of the decidua basalis at d21), the control mechanism(s) responsible for these cell-type-specific, spatiotemporally regulated expression patterns remain to be clarified.
Abbreviations
- Al
allantois
- Am
amnion
- Amc
amniotic cavity
- BZ
basal zone (trophospongium)
- CT
connective tissue
- CV
chorionic villus
- DB
decidua basalis
- DC
decidua capsularis
- Ep
epidermis (fetal skin)
- EEC
extraemhryonic cavity
- EEM
extraemhryonic membranes
- ES
endometrial stroma
- GE
glandular epithelium
- GJ
gap junction
- L
labyrinth
- LE
luminal epithelium
- M
myometrium
- MS
mesometrial stroma (metrial gland)
- PE
parietal epithelium
- PYS
parietal yolk sac
- RM
Reichert’s membrane
- TB
trophoblast
- TB GC
trophoblast giant cell
- U
uterus
- U/YSC
uterus/yolk sac cavity
- VE
visceral epithelium
- VYS
visceral yolk sac.
ACKNOWLEDGEMENTS
The authors are grateful for the outstanding technical assistance of Jessica Van Leeuwen, Robert Safarik, and John Leopart, secretarial assistance from Theresa Byrd-Talley, Rebecca Cochran, Laura Goe and Cheryl Negus, and for the constructive suggestions from Drs Allen Enders, Stanley Glasser and Alerick Welsh during the course of this study. This work was supported by a grant from the NIH (GM 37904) and funds from the R. W. Johnson Pharmaceutical Research Institute.